| Symbol | LFCR |
|---|---|
| Name | LIFECORE BIOMEDICAL, INC. \DE\ |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 3515 LYMAN BOULEVARD, CHASKA, MN 55318 |
| Telephone | 9523684300 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001005286 |
| Description | None |
(30% Negative) LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Reports Q2 2026 Financial Results
Read moreLifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Read moreNew Form DEF 14A - LIFECORE BIOMEDICAL, INC. \DE\ <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001005286-26-000012 <b>Size:</b> 7 MB
Read moreSalus Thomas D. 🔴 sold 24.6K shares of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) at $5.20 Transaction Date: Apr 14, 2026 | Filing ID: 000004
Read moreLifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit
Read moreLifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
Read moreLifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
Read moreLifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
Read more